No Borders (OTC: NBDR) today announced that it has successfully filed the first blockchain provisional patent for its CBD LabChain platform. According to the update, the provisional patent, registered as Application Serial #62969531 with the USPTO on Feb. 3, 2020, now allows NBDR’s CBD LabChain platform to operate with “Patent Pending” identifiers and messaging. This marks the very first Patent Pending achievement for the No Borders family of companies and supports the company’s mission to impact shareholder value by building a valuable portfolio of IP assets. “It has been a long road to get to this day and I am stoked to share our first patent filing with the world! This filing marks a milestone for our Company and our amazing shareholders,” No Borders, Inc. CEO Joseph Snyder said in the news release. “We have consistently stated that No Borders is committed to building and owning a strong IP portfolio and I am proud that we have multiple Trademark approvals, in addition to this initial Patent filing. A giant thank you to both Chris Brown and the No Borders Labs teams as well as Andrew Coldicutt and Keith Alan Miller for the legal work they put in to get our filings prepped and really doing an amazing job on behalf of No Borders, Inc.”
To view the full press release, visit http://cnw.fm/EuGR8
About No Borders Inc.
No Borders, Inc. (OTC: NBDR) is a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value through technological superiority and Intellectual Property ownership across its portfolio of assets. The Company’s portfolio of brands includes:
No Borders is headquartered in Arizona with resources in the U.S., South America, Asia and Europe. For more information, visit the Company’s website at www.NBDR.co.
NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://cnw.fm/NBDR
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.